公司資料
Lipella Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- LIPO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月24日
—
市值
股價為何變動
Current closing-price context is not available for LIPO.
公司概覽
業務概覽
Lipella Pharmaceuticals is a specialty pharmaceutical company focused on localized therapies for difficult urologic and inflammatory conditions. Its story is built around reformulating existing drugs for targeted delivery.
所在地與產業分類
Lipella is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and drug-delivery development.
商業模式特徵
The company depends on clinical development, regulatory progress, and the ability to create value through localized formulations. Investors usually watch data updates and pipeline execution.
生技產業定位
Lipella occupies a narrow specialty-pharma niche within biotech. It is a formulation story where better delivery could matter as much as the active ingredient.
未來催化劑
- Lipella’s catalysts are intravesical and mucosal-delivery programs, especially any clinical update that keeps the pipeline credible. The company still needs human proof.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。